Nikko Asset Management Americas’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,136,936
Closed -$40.5M 192
2024
Q2
$40.5M Sell
4,136,936
-3,044,752
-42% -$37.1M 0.47% 46
2024
Q1
$108M Sell
7,181,688
-283,186
-4% -$5.14M 1.08% 26
2023
Q4
$161M Sell
7,464,874
-222,772
-3% -$4.11M 1.55% 15
2023
Q3
$143M Sell
7,687,646
-166,836
-2% -$3.89M 1.71% 18
2023
Q2
$199M Sell
7,854,482
-179,306
-2% -$4.51M 2.09% 14
2023
Q1
$206M Sell
8,033,788
-91,443
-1% -$2.45M 2.37% 15
2022
Q4
$192M Sell
8,125,231
-70,088
-0.9% -$1.89M 2.77% 10
2022
Q3
$210M Sell
8,195,319
-91,609
-1% -$3.21M 2.68% 12
2022
Q2
$272M Sell
8,286,928
-163,361
-2% -$6.94M 3.36% 10
2022
Q1
$611M Sell
8,450,289
-304,769
-3% -$22M 4.49% 5
2021
Q4
$810M Buy
8,755,058
+1,349,776
+18% +$161M 4.26% 6
2021
Q3
$933M Buy
7,405,282
+1,714,753
+30% +$250M 4.01% 4
2021
Q2
$946M Buy
5,690,529
+1,244,967
+28% +$202M 3.71% 6
2021
Q1
$808M Buy
4,445,562
+1,621,495
+57% +$376M 3.96% 3
2020
Q4
$565M Buy
2,824,067
+1,791,008
+173% +$364M 3.21% 5
2020
Q3
$229M Buy
1,033,059
+933,432
+937% +$198M 2.03% 12
2020
Q2
$19M Sell
99,627
-107,482
-52% -$18.8M 0.25% 63
2020
Q1
$32.1M Sell
207,109
-711,246
-77% -$82.7M 0.6% 43
2019
Q4
$76.9M Sell
918,355
-122,972
-12% -$9.36M 1.21% 25
2019
Q3
$70.5M Buy
1,041,327
+319,556
+44% +$21M 1.25% 22
2019
Q2
$47.9M Buy
721,771
+551,755
+325% +$32.2M 0.94% 33
2019
Q1
$9.45M Buy
170,016
+169,502
+32,977% +$10.3M 0.25% 67
2018
Q4
$25K Buy
+514
New +$31.5K ﹤0.01% 139

Other funds holding TDOC

Nikko Asset Management Americas's TDOC Position: Q3 2024 in Review

Nikko Asset Management Americas sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 4,136,936 shares — an estimated $40.5M sold.

Nikko Asset Management Americas first reported a position in TDOC in Q4 2018 and held it in 23 quarters. The position peaked at $946M in Q2 2021. 365 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Nikko Asset Management Americas reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • Nikko Asset Management Americas sold 4,136,936 Teladoc Health shares in Q3 2024, an estimated $40.5M.
  • Nikko Asset Management Americas first reported a position in Teladoc Health in Q4 2018 and held it in 23 quarters.
  • Nikko Asset Management Americas's Teladoc Health position peaked at $946M in Q2 2021.
  • 365 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Nikko Asset Management Americas's 13F filing for Q3 2024, filed 7 Nov 2024.